Which CBD Oil to Choose in 2026? A Practical Buyer’s Guide

The CBD oil label can be fictional, and this has been calculated. Bonn-Miller and co-authors bought 84 products online from 31 companies and tested their actual composition: only 30.95% of products had a declaration consistent with content within accepted tolerance (JAMA, 2017). The rest contained less or more cannabidiol than promised, and THC was detected in one in five samples. This guide leads through six things that can be checked before purchase: extract spectrum, concentration, carrier oil, independent laboratory report, producer transparency, and price per milligram. Added to this are the legal status and what today’s European scientific assessment says about cannabidiol safety. You will not find health promises or daily dose recommendations here, as both would be inconsistent with current knowledge.

KEY INFORMATION
- 30.95% of 84 online-purchased products had CBD content consistent with the declaration (Bonn-Miller et al., JAMA 2017).
- The entourage effect remains a hypothesis: Russo in 2011 wrote about synergy conditionally and proposed methods to study it.
- Absolute bioavailability of CBD was measured in humans only for inhalation; no study established it for oral use (Millar et al., 2018).
- The 0.3% threshold applies to the plant and is the sum of delta-9-THC and THCA, not delta-9-THC alone.
- CBD safety cannot be established for people under 25, pregnant and breastfeeding women, and those taking medications (EFSA, 2026).
- Price per milligram in the oil category at u Bucha, as of August 10, 2026, is about 0.10-0.13 PLN for CBD.

What exactly are you buying when you take CBD oil?

You are buying an extract from fiber hemp dissolved in fat. The extract itself is a dense, dark resin-like substance, and no one sells it in this form. The manufacturer dilutes it in a carrier oil, most often MCT oil from coconut, hemp seed oil, or olive oil.

The percentage on the label describes the cannabidiol share in the total product mass. A 10 ml bottle with a 10% declaration contains 1000 mg CBD, and with full or broad spectrum also minor cannabinoids and terpenes. This is arithmetic, not a recommendation: how much of the bottle corresponds to a dose is a question for a doctor, not the label.

A separate issue is terminology, which confuses most buyers. CBD oil is not the same as hemp seed oil, also called hemp oil. The latter is pressed from seeds only, sold in the food section, and contains only trace amounts of cannabinoids because seeds simply do not have them. If the label shows only “hemp seed oil” without CBD content in milligrams, you are buying a food product, not a cannabinoid preparation.

The extraction method is the third element of this puzzle. Supercritical CO2 extraction allows extracting cannabinoids and terpenes without solvent residues but requires expensive equipment. Ethanol extraction is cheaper and yields a clean product if the alcohol is thoroughly evaporated. Hydrocarbon solvents require confirmation in the lab report that none remain in the final oil. A manufacturer unwilling to disclose the method has just answered the question.

It is worth clarifying one distinction that recurs throughout the text. The manufacturer’s declaration and the lab result are two different things, and they match less often than intuition suggests. Everything described below as a selection criterion boils down to whether the declaration can be verified in a document issued by someone other than the seller.

Which CBD spectrum to choose: full, broad, or isolate?

Spectrum indicates what besides cannabidiol remains in the extract, and this is the first purchase decision. Full spectrum retains the entire plant profile including trace THC, broad spectrum the same profile without THC, and isolate is pure cannabidiol with purity up to 99%.

The argument for full formulas is the entourage effect, the hypothesis that cannabinoids and terpenes enhance each other. It is worth knowing what the author really wrote. Russo in 2011 analyzed cannabis terpenoids and their possible interactions with phytocannabinoids but formulated synergy conditionally and proposed methods to study it in future experiments (British Journal of Pharmacology). This is a hypothesis with good chemical justification, not a measured difference in product potency. Statements like “isolate requires higher doses for the same effect” are not supported in this work.

The terpene profile itself is a real comparative criterion because the lab report shows it. Russo discusses limonene, myrcene, alpha-pinene, linalool, and beta-caryophyllene, reminds that terpenoids share a precursor with phytocannabinoids, and that as flavor and aroma components they have GRAS status in the USA. He also notes they act at concentrations of single nanograms per milliliter of serum. If the producer declares broad or full spectrum, the report should list specific terpenes, not just the word “terpenes.”

Choosing spectrum is not a choice between better and worse but a choice of risk profile. Full spectrum takes the most from the plant and risks most in sobriety control. Isolate removes risk and loses possible synergy, which no one has measured in humans yet. Broad spectrum is in the middle and therefore most often chosen. Differences between distillate and isolate are detailed in a separate comparison.

Which CBD oil concentration to choose for yourself?

Concentration is dosing convenience, not product strength. The same amount of cannabidiol in 5% and 20% oil is the same amount of cannabidiol, just in a different number of drops. Low concentration allows finer steps, high concentration shortens dosing.

Before arithmetic, one reservation that cannot be omitted. The European Food Safety Authority updated in 2026 its position on cannabidiol as novel food and derived a provisional safe dose by benchmark dose method with uncertainty factor 400 (EFSA Journal). It is 0.0275 mg per kilogram body weight per day, about 2 mg for a 70 kg person, and applies only to preparations with cannabidiol purity at least 98%, without nanoparticles. This is much less than doses described in online guides, and the often repeated 1500 mg per day number attributed to WHO comes from a document no longer available at its address. The panel added a sentence to appear in every dosing text: CBD safety cannot be established for people under 25, pregnant and breastfeeding women, and those taking medications. Therefore, this guide does not provide any daily dose.

The practical conclusion is opposite to the intuition “the stronger, the better.” High concentration makes measuring small doses harder because one drop carries several times more substance. If you buy for the first time, lower concentration gives more room to observe your body’s reaction. Comparison of concentrations from 5 to 30 percent is described in detail in a separate article.

Why won’t you find a dose table by body weight here?

Because there is no basis to build it. For a healthy adult, no one has established cannabidiol dose per kilogram, and conversion tables circulating in store guides come from copying others’ compilations, not measurements. A dose table by body weight would look like a measurement result that no one performed.

The only body weight-related number with grounding today goes opposite to recommendations. The EFSA provisional safe dose (EFSA Journal, 2026), given above in the concentration section, is a ceiling above which the agency does not guarantee safety, not a threshold from which anything starts to work. You cannot build a dose per kilogram from it because it answers a different question.

Numbers in studies look quite different and do not translate to store shelves. In Linares’ study, 57 healthy men received a single 150, 300, or 600 mg cannabidiol dose before simulated public speaking: only the middle dose reduced anxiety, and both extremes did not differ from placebo (Linares et al., Brazilian Journal of Psychiatry, 2019). The dose-effect curve is an inverted U, so more does not mean stronger. This is exactly why a table with increasing numbers would mislead rather than help choice.

If you still want to try cannabidiol, determine the amount with a doctor or pharmacist, especially if taking medications regularly. This is the only way that considers your situation, not an averaged number from someone else’s compilation.

How much cannabidiol is in a drop and what is known about duration?

Drop content results from product arithmetic. A 10 ml bottle of 5% oil contains 500 mg cannabidiol, and how much per drop is shown in the table above in the concentration section. This describes product content, not how much to use. Exact drop volume depends on pipette calibration and carrier density, so producers state milligrams directly on the label.

Meal composition changes this arithmetic more than concentration differences. In a phase 1 study with healthy volunteers, taking cannabidiol with a fat-containing meal increased its bioavailability about four to five times compared to fasting (Taylor et al., CNS Drugs, 2018). The same bottle content thus gives a completely different exposure after breakfast than before. The number refers to the meal, not the carrier: no one has measured the advantage of one carrier oil over another in humans, as the next section explains.

Duration depends on administration route, but we do not give minutes because no measurements back it. Capsules and edibles pass through the digestive system and liver, where cytochrome P450 enzymes metabolize some substances, so they act later than oil held under the tongue. A pharmacokinetic review, discussed next, shows only that maximum concentration appears within the first four hours, with limited and sometimes conflicting data.

Which carrier oil provides better absorption?

The answer is: no one has properly measured this in humans, and anyone giving percentage advantages of one carrier over another goes beyond data. Millar and co-authors reviewed 792 papers and found 24 with cannabidiol pharmacokinetic parameters in humans (Frontiers in Pharmacology, 2018).

Their conclusion is cautious and therefore credible. Absolute bioavailability was measured only for inhalation and was 31%. No other administration route was studied despite intravenous forms being available. They noted two useful things for carrier choice: maximum concentration increases after a meal and in fat-based formulations. EFSA confirms this, stating cannabidiol bioavailability varies depending on the carrier matrix and food intake.

The same work clarifies another frequent question: how long cannabidiol stays in the body. Half-life ranged from 1.4 to 10.9 hours after oral mucosa spray, 2 to 5 days with chronic oral administration, about one day after intravenous administration, and about 31 hours after smoking. Maximum concentration was reached within the first four hours, faster for inhalation than oral. Authors emphasize data are limited and sometimes conflicting.

What this means for the three most popular carriers. Fractionated MCT coconut oil is flavor-neutral and chemically stable, facilitating storage and dosing. Hemp seed oil brings its own fatty acid profile and a distinct grassy taste that overlays the extract flavor. Olive oil is well tolerated and sometimes used in studies but has a shorter shelf life after opening. None has proven bioavailability advantage over others in humans.

Hemp seed oils have a separate legal limit rarely mentioned by producers. Commission Regulation (EU) 2023/915 sets the maximum THC level at 3.0 mg/kg for hemp seeds and processed products and 7.5 mg/kg for hemp seed oil, counting the sum of delta-9-THC and THCA expressed as delta-9-THC.

What should a laboratory report contain?

An independent laboratory report, abbreviated COA, is the only proof that the bottle contains what the label promises. Without it, you buy a declaration. The scale of the problem is shown by Bonn-Miller et al.’s study published in JAMA: of 84 products bought online, 26.19% contained less cannabidiol than the label stated, and 42.85% more (JAMA, 2017).

They also noted something less often mentioned. THC was detected in 18 of 84 samples, i.e., 21.43%, and they pointed out such concentrations may cause psychoactive effects, especially in children. For a professional driver or athlete under doping control, this is not a technical detail but a real risk with a product described as THC-free.

A good report has six elements and checking them takes a minute. It lists the cannabinoid profile with separate entries for CBD, CBDA, THC, and THCA. It provides results for heavy metals, pesticide residues, and solvents. It contains batch number matching the bottle, sample collection date, laboratory name with accreditation, and method detection limits for each substance. A report without batch number or lab accreditation is not a report but a graphic.

Separately check if specific values are given, not just annotations like “pass” or “compliant.” The European Union sets binding maximum contamination levels in food in Regulation 2023/915, so the lab has a reference and no reason to hide numbers. A broader guide on what to check before purchase is described separately.

How to check the producer and raw material origin?

A transparent producer provides four things without being asked: address, raw material origin, extraction method, and a lab report assigned to a specific batch. Missing any of these is information itself, as none are trade secrets.

Raw material origin has legal significance, not just marketing. Since January 1, 2023, hemp varieties eligible for support under the Common Agricultural Policy may contain up to 0.3% THC, based on Regulation (EU) 2021/2115. Previously, the EU threshold was 0.2% from Regulation 1307/2013, repealed on January 1, 2023. Raw material from registered cultivation in a member state has documented variety and profile, unlike material without papers.

When verifying a brand, a simple rule applies: check what cannot be bought. Reviews and social media activity can be ordered, but tax ID, product batch history, and contact to quality responsible person cannot. A brand existing only a few months without history may be a rebranding of a previous company, which does not determine quality but removes the only easy credibility proof: time.

A control question to ask the seller before purchase is: from which batch is the bottle I will get, and can I see the report for it? The answer “we have reports on the website” is not an answer because a two-year-old report describes a different product than the one that will reach your shelf.

How much should a milligram of cannabidiol cost?

Price per milligram is the only measure allowing comparison of two different packages. It is calculated by dividing the bottle price by declared cannabidiol content in milligrams, not by volume in milliliters. Without this, a larger package always looks more expensive, though usually cheaper per substance.

For scale: in the oil category at u Bucha, as of August 10, 2026, cannabidiol price per milligram ranges about 0.10-0.13 PLN, with the lower end for higher concentration packages. Cannabigerol oils are clearly more expensive, about 0.16-0.20 PLN per milligram, because raw material for this cannabinoid is harvested earlier and yields less. The range is given for the category and date because the catalog changes faster than the article.

Extremes in both directions signal to check the lab report, not immediate proof of fraud. A price clearly below market may mean lower actual content than declared, exactly the defect Bonn-Miller measured. A clearly higher price may be justified for rarer cannabinoids or modified matrix formulations but often covers packaging and positioning in a drugstore. In both cases, the deciding document is the batch report.

One arithmetic trap at the end. If the product contains less cannabidiol than the label declares, the actual price per milligram rises proportionally to the discrepancy. A product with half the declared content effectively costs twice as much as the receipt calculation shows, and no promotion will compensate.

From this follows the order in which to look at offers. First, check if the product has a batch report, then calculate price per milligram, and only then compare with others. The reverse order leads to comparing numbers that may not match bottle content.

What is the legal status of CBD oils in Poland?

Cannabidiol is not listed in any controlled substances lists, and fiber hemp preparations are legal in Poland. The definition of the plant, not the finished product composition, determines this and changes the lab test result.

Fiber hemp are Cannabis sativa L. plants with the sum of delta-9-THC and tetrahydrocannabinolic acid in flower or fruiting tops, from which resin has not been removed, not exceeding 0.3% dry weight, rounded to one decimal place. The basis is Art. 4 point 5 of the Act of July 29, 2005 on Counteracting Drug Addiction (consolidated text Dz.U. 2023 item 1939), as amended by the Act of March 24, 2022 (Dz.U. 2022 item 763), effective May 7, 2022. The threshold is calculated as the sum of delta-9-THC and THCA, not delta-9-THC alone.

The national threshold corresponds to the EU threshold but does not derive from it. These are two separate regulations with the same numerical value: the Polish one is set by the Act on Counteracting Drug Addiction, the EU one by Regulation 2021/2115 effective January 1, 2023. The often repeated statement that the Polish threshold comes from EU law is false, as is attributing the 0.3% threshold to Regulation 1307/2013, which set 0.2% and was repealed.

The second layer concerns food. Cannabidiol remains under the novel food procedure in the EU, and EFSA’s 2026 position indicates data gaps reported earlier remain open. The practical effect for buyers is that CBD products cannot carry health claims, and sanitary notification is not novel food authorization and does not change ingredient status. Advertising promising treatment violates regulations regardless of product quality.

The third issue concerns what should not be in the basket. Hexahydrocannabinol, sold as HHC, is a controlled substance in Poland. Since July 28, 2026, it is listed in the psychotropic substances list in group II-P, previously in group I-P, and moving between groups is not legalization. If a store offers HHC products alongside CBD oils, it signals about the store, not an offer to consider.

What is known today about cannabidiol safety?

Less than product popularity suggests, and this is an institutional finding, not an opinion. The EFSA panel assessed cannabidiol as novel food and in the 2026 update stated that data gaps reported in 2022 remain open because new studies have non-standardized protocols, short observation times, and concomitant treatments.

What the panel noted on the risk side. Animal studies showed consistent liver toxicity, with liver mass and histopathological changes as the most sensitive endpoints. Human data indicated hepatotoxic potential, especially when cannabidiol was taken with other drugs. Gastrointestinal symptoms were reported at higher doses, and neurological and psychiatric safety data were insufficient. Hormonal disorders, including altered thyroid hormone levels, and adrenal histopathological changes were noted. Immunotoxicity was not studied in any reviewed research.

Pregnancy and age are separate issues. Cannabidiol crosses the placenta and accumulates in the body, and prenatal exposure has been linked to long-term, sex-dependent neurodevelopmental effects. Hence the panel’s conclusion: cannabidiol safety cannot be established for people under 25, pregnant and breastfeeding women, and those taking medications.

For buyers, this means a concrete change in thinking about the category. CBD oil is not a neutral product anyone can try without consequences but a preparation with recognized risks and an unsettled safety profile in several large groups. If you belong to any of these, decide with a doctor, not based on a store website description.

How to store and transport CBD?

Cannabidiol degrades under oxygen, UV radiation, and heat. Stability studies show that CBD dissolved in oil is significantly less stable than pure CBD powder, and storage conditions realistically determine product shelf life (Kosović et al., 2021). Improper storage accelerates potency loss noticeably faster than the declared expiration date.

Optimal conditions are a tightly closed dark glass bottle, cool place, no direct light, and low humidity: kitchen cabinet or drawer works better than bathroom, windowsill, or car in summer. Expiration date and recommended use time after opening are given by the producer on the packaging. Some users keep oil in the fridge, which is safe, though it must be warmed to room temperature before use because cold oil thickens and is harder to dose precisely with a dropper.

Before international flights, check local regulations of destination and transit countries, and keep oil in original packaging with a clear label, preferably with a printed COA. This is rarely needed but provides real peace of mind in customs control.

Signs of degradation are color change from light golden to dark red or brown, thickening, and bitter taste. Degraded oil is not dangerous but loses some efficacy: if the product is just past expiration but looks and tastes normal, it probably retained most potency, though the effect will be weaker than fresh oil. With clear color, smell, or consistency changes, better buy a new bottle than rely on uncertain expired product effect.

What mistakes do buyers make most often?

The most common mistakes do not stem from lack of chemical knowledge but from comparing the wrong things. Four recur most often regardless of buyer experience, each with a simple correction.

• Comparing bottle prices instead of price per milligram. Two bottles at the same price may differ fourfold in substance content. Calculate before judging if something is expensive.
• Ignoring the laboratory report. This is the only measurable defect on this list and has been measured: nearly 70% of tested products had labels inconsistent with content (Bonn-Miller et al., JAMA 2017).
• Buying the highest concentration at the start. High concentration is not a stronger product but a denser solution, and small doses are hardest to measure from it.
• Confusing hemp seed oil with CBD oil. Food product from seeds contains trace cannabinoids and does not replace extract-based preparation.

The fifth mistake is more serious because it concerns health, not wallet. It is skipping consultation with a doctor when taking medications regularly. Cannabidiol affects enzymes responsible for drug metabolism and P-glycoprotein involved in excretion, so the potential for interactions with commonly used preparations is high (Journal of Clinical Medicine, 2019). Adverse effects occurred in nearly half of CBD users and depended on dose size, with elevated aminotransferase activity and sedation among the most common.

How to assess CBD oil in a minute before purchase?

The eight points below are our own checklist, composed of things that can be checked on the product page before adding to the cart. It is not an industry norm or someone else’s standard but a set of questions a transparent seller answers effortlessly.

If the product passes all eight points, you buy consciously. If it fails on the lab report or raw material origin, skip it regardless of price and reviews. These two points are the only ones that cannot be verified after purchase, while all others can be compensated by asking store staff.

It is worth going through the list in the order shown in the table. Start with numbers because without milligram content you cannot calculate price or compare products. Finish with the producer because it is the most time-consuming point and pointless to check if the offer failed earlier. The whole process takes less time than reading marketing description on the same page.

Summary: what to really base your decision on

Choosing CBD oil boils down to six verifiable things: spectrum matched to your risk profile, concentration matched to dosing convenience, carrier with known composition, lab report for a specific batch, transparent producer, and price calculated per milligram.

Three things from this guide are worth remembering longer than until purchase. The entourage effect remains a hypothesis, not a measured advantage of full formulas over isolate. Oral cannabidiol bioavailability has not been established in humans, so promises of percentage advantage of one carrier over another are invented. The 0.3% threshold applies to the plant and is calculated as the sum of delta-9-THC and THCA, which causes misunderstandings when reading reports.

What this text deliberately does not contain: daily dose recommendations, health promises, and indication of a “best” product. The first is absent because European safety assessment does not allow formulating it for people taking medications. The second is absent because no health claim for cannabinoids has been approved. The third is absent because the catalog changes faster than the article, and criteria from this list outlive any single product.

If you take medications regularly, are pregnant, or breastfeeding, all above criteria become secondary to consulting a doctor. European safety assessment has not established a safety profile for these groups, and the best-documented product does not change that. This is the only point in this guide that cannot be resolved by a lab report.

The full, up-to-date offer of cannabinoid-containing oils is in the oils category at u Bucha store.

Sources

Each item was checked at the source for work identity and abstract or regulation content.

• Bonn-Miller M.O. et al. (2017). Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA.
• Russo E.B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology.
• Millar S.A. et al. (2018). A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans. Frontiers in Pharmacology.
• Brown J.D., Winterstein A.G. (2019). Potential Adverse Drug Events and Drug-Drug Interactions with Cannabidiol Use. Journal of Clinical Medicine.
• EFSA NDA Panel (2026). Update of the statement on safety of cannabidiol as a novel food. EFSA Journal.
• Act of July 29, 2005 on Counteracting Drug Addiction, consolidated text Dz.U. 2023 item 1939, Art. 4 point 5.
• Act of March 24, 2022 amending THC threshold, Dz.U. 2022 item 763, effective May 7, 2022.
• Regulation (EU) 2021/2115, Art. 4 para. 4, effective January 1, 2023.
• Commission Regulation (EU) 2023/915, Annex I, THC limits in food from hemp seeds.

Frequently Asked Questions

Which CBD oil should I start with if I am buying for the first time?

With a product that has a laboratory report for a specific batch and a clearly defined spectrum. Lower concentration makes it easier to measure small doses because one drop contains less substance. How much and whether to use it at all is decided by a doctor, especially if you are taking medications regularly.

What is the difference between full spectrum, broad spectrum, and isolate?

Full spectrum retains the entire plant profile including trace THC, broad spectrum the same profile without THC, and isolate is pure cannabidiol with purity up to 99%. The entourage effect, cited as an advantage of full formulas, was conditionally formulated by Russo in 2011, who proposed methods to study it.

Does the carrier oil affect cannabidiol absorption?

Probably yes, but no one has measured the scale in humans. Millar and co-authors established absolute bioavailability only for inhalation, which was 31%, and noted increased maximum concentration after a meal and in fat-based formulations (Frontiers in Pharmacology, 2018). Percentage advantages of specific oils are unjustified.

Why check the laboratory report before purchase?

Because the label can be inconsistent with the content. In the study by Bonn-Miller and co-authors, 30.95% of 84 products bought online matched the label, and tetrahydrocannabinol was detected in 21.43% of samples (JAMA, 2017). A report for a specific batch is the only proof that cannot be replaced by a seller’s opinion.

How to calculate the price per milligram of cannabidiol?

Divide the price of the bottle by the declared CBD content in milligrams, not by volume. In the oil category at u Bucha, as of August 10, 2026, it is about 0.10-0.13 PLN per milligram of cannabidiol, and for oils with cannabigerol significantly more, because the raw material for this cannabinoid yields less.

Are CBD oils legal in Poland?

Yes, if they come from fiber hemp. Cannabidiol is not listed in controlled substances, and the 0.3% threshold applies to the plant and is calculated as the sum of delta-9-THC and THCA, according to Art. 4 point 5 of the Act on Counteracting Drug Addiction effective from May 7, 2022.

Can the manufacturer claim that the oil helps with something?

No. No health claims for cannabinoids have been approved, and cannabidiol remains under the novel food procedure in the European Union. Sanitary notification is not authorization and does not change the ingredient’s status, so advertising promising treatment violates regulations regardless of product quality.

Can CBD be combined with medications taken regularly?

Only after consulting a doctor. Cannabidiol affects enzymes metabolizing drugs and P-glycoprotein, so the potential for interactions is high, and adverse effects occurred in nearly half of users (Brown and Winterstein, Journal of Clinical Medicine, 2019). EFSA has not established safety for people taking medications.

This article is informational and educational. It contains internal links to product categories available at u Bucha store. Prices and specifications may change: check current data on the product page before purchase.

Author: Michał Waluk · Published: 2026-05-11 · Updated: 2026-09-22